| Literature DB >> 29202124 |
Fereshte Torabi1,2, Majid Malekzadeh Shafaroudi1,2, Nourollah Rezaei2.
Abstract
BACKGROUND: Cyclophosphamide (CP) has been known as an anticancer drug with several side effects on various organs such as a male reproductive system that can cause infertility.Entities:
Keywords: Cyclophosphamide; Melatonin; Sperm; Toxicity; Zinc oxid
Year: 2017 PMID: 29202124 PMCID: PMC5601931
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
Effects of zinc oxide nanoparticles, melatonin and cyclophosphamide on body and relative testis and epididymis weights of rats in control and treated groups
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|
| Initial body weight (gr) | 214.00±10.00 | 237.70±16.23 | 242.29±6.80 | 203.14±4.74 | 207.86±6.46 | 210.00±6.65 | |
| Final body weight (gr) | 364.29±18.80 | 242.29±59.04[ | 297.71±40.08[ | 240.00±37.19 [ | 336.14±24.88b[ | 343.14±45.48 | |
| Right testis | |||||||
| Absolute weight testis (gr) | 1.54±1.75 | 1.15±1.37 | 1.32±0.09 | 1.20±0.11 | 1.42±0.11 | 1.50±0.13 | |
| Relative weight testis (gr) | 0.71±0.08 | 0.50±0.06 [ | 0.54±0.04 [ | 0.58±0.04 [ | 0.68±0.06b [ | 0.71±0.06 | |
| Left testis | |||||||
| Absolute weight testis (gr) | 1.57±1.70 | 1.21±0.14 | 1.36±0.11 | 1.22±0.11 | 1.46±0.08 | 1.52±0.16 | |
| Relative weight testis (gr) | 0.73±0.08 | 0.52±0.08 [ | 0.55±0.05 [ | 0.59±0.04 [ | 0.70±0.04b [ | 0.72±0.07 | |
| Right epididymis | |||||||
| Absolute weight epididymis (gr) | 0.60±0.07 | 0.43±0.12 | 0.51±0.05 | 0.48±0.11 | 0.57±0.05 | 0.62±0.10 | |
| Relative weight epididymis (gr) | 0.28±0.04 | 0.19±0.04 [ | 0.20±0.02 [ | 0.23±0.04 | 0.27±0.02b[ | 0.29±0.04 | |
| Left epididymis | |||||||
| Absolute weight epididymis (gr) | 0.63±0.07 | 0.44±0.13 | 0.51±0.06 | 0.44±0.09 | 0.61±0.07 | 0.65±0.08 | |
| Relative weight epididymis (gr) | 0.29±0.04 | 0.19±0.04 [ | 0.21±0.02 [ | 0.21±0.04 [ | 0.29±0.03b [ | 0.30±0.03 | |
The data are expressed as mean ± SD (Standard deviation). Statistical significance is represented as follows:
nZno: nano zinc oxid
Mel: melatonin
P: cyclophosphamide
p< 0.05,
p< 0.01,
p< 0.001,
: compared with control group;
: compared with CP group
Figure 1Sperm parameters in control and treated groups. (Mean±STD), Statistical significance is represented as follows: *p<0.05, **p<0.01, ***p<0.001, a: compared with control group; b: compared with CP group
Figure 2Evaluation of spermatozoa viability. a: Live sperm, with uncolored head. b: dead sperm, with red head (Eosin Y Nigrosine ×1000).
Johnsen’s score, seminiferous tubule diameter and germinal epithelium height in different groups
|
|
|
|
|
|---|---|---|---|
| Control | 9.52 ± 0.10 | 295.14±5.69 | 98.64 ± 3.59 |
| CP | 7.45 ± 0.27[ | 207.00 ±11.07 [ | 60.50 ± 2.43 [ |
| Mel+ CP | 8.57± 0.39 [ | 249.03 ± 6.73 [ | 79.71 ± 2.56 [ |
| nZno+ CP | 8.45 ± 0.38 [ | 250.71 ± 17.32 [ | 82.25 ± 2.77 [ |
| nZno+ Mel+ CP | 9.18 ± 0.21 [ | 287.28 ±14.32 [ | 95.07 ± 1.92 [ |
| nZno+ Mel | 9.30 ± 0.25 | 297.00 ± 7.70 | 101.21 ± 3.36 |
The data are expressed as mean±SD. Statistical significance is represented as follows:
STD: seminiferous tubule diameter
GEH: germinal epithelium height
CP: cyclophosphamide
Mel: melatonin
nZno: nano zinc oxid
p< 0.001 compared with control group
p< 0.001 compared with CP group.
Figure 3Normal testis of the control group, notice the normal spermatogenesis. B-E: Testes in cyclophosphamide (CP)-administered group showing degeneration, Germinal epithelium height reduction and incomplete spermatogenic series (Up down arrow), vacuolization (*) and exfoliation of germ cells into the lumen (*) and Multi-nucleated giant cell formation in some of the seminiferous tubule (arrow head). F: Mel+ CP group. G: nZno+ CP group. H: nZno+ Mel+ CP group, improvement of spermatogenesis of rats treated with CP plus simultaneous administration nZno and Mel. I: nZno+ Mel group. (H&E, ×400)